Hyperlipidemia in coronary heart disease: a biochemical genetic approach.
D000429:Alcohol Oxidoreductases / Q000378:metabolism; D002478:Cells, Cultured; D002784:Cholesterol / Q000096:biosynthesis; D003327:Coronary Disease / Q000209:etiology* / Q000235:genetics*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005347:Fibroblasts / Q000201:enzymology; D005977:Glutarates / Q000378:metabolism; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D006937:Hypercholesterolemia / Q000235:genetics / Q000378:metabolism; D006949:Hyperlipidemias / Q000150:complications* / Q000235:genetics*; D008075:Lipoproteins, HDL / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008798:Mevalonic Acid / Q000378:metabolism; D011485:Protein Binding; D013960:Thyroid Function Tests; D013997:Time Factors
D004791:Enzyme Inhibitors; D005977:Glutarates; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D002784:Cholesterol; D000429:Alcohol Oxidoreductases; D008798:Mevalonic Acid